Healthcare ETFs offer defensive stability and growth through biotech, pharma, and weight-loss innovations.

Healthcare ETFs provide a blend of defensive stability and growth potential by covering broad healthcare sectors and specialized themes like biotechnology, pharmaceuticals, and weight-loss treatments. Aging populations and rising healthcare demand support steady growth, while biotech ETFs offer high innovation-driven upside with more volatility. Pharmaceutical ETFs focus on established drugmakers with stable revenues, and weight-loss ETFs target the fast-growing obesity treatment market, including GLP-1 drugs. These options allow investors to diversify with exposure to both steady demand and breakthrough medical innovations.